A 38-year-old woman from Delhi presents with a 6-month history of a painless, slow-growing mass in the left parotid region. On examination, the mass is soft, mobile, and non-tender, located anterior to the angle of the mandible. Facial nerve function is intact. Ultrasound shows a well-defined, hypoechoic lesion measuring 2.5 cm with no cervical lymphadenopathy. The patient is anxious about surgery and asks if the mass can be managed conservatively. What is the most appropriate next step in management?

Explanation

## Clinical Scenario Analysis This patient presents with features suggestive of a **benign parotid mass**: - Slow growth over 6 months (benign pattern) - Soft, mobile, non-tender (benign characteristics) - Intact facial nerve function (no nerve involvement) - Well-defined, hypoechoic lesion on ultrasound (suggests pleomorphic adenoma or Warthin's tumor) - No cervical lymphadenopathy (no metastatic features) ## Rationale for FNAC as Next Step **Key Point:** In a clinically benign-appearing parotid mass, **FNAC is the appropriate next step** to confirm histological diagnosis and guide management (conservative vs. surgical). **High-Yield:** FNAC serves three critical functions: 1. **Tissue diagnosis:** Distinguishes benign (pleomorphic adenoma, Warthin's tumor, oncocytoma) from malignant lesions 2. **Risk stratification:** Benign lesions can be observed; malignant lesions require surgery 3. **Patient counseling:** Confirmed benign diagnosis allows informed discussion of observation vs. elective surgery ## FNAC Accuracy in Parotid Pathology | Feature | Sensitivity | Specificity | Utility | |---------|-------------|-------------|----------| | Benign diagnosis (pleomorphic adenoma) | 85–95% | 95–98% | High confidence for observation | | Malignant diagnosis | 80–90% | 98–100% | Mandates surgery | | Inconclusive/atypia | 5–15% | — | May require repeat FNAC or core biopsy | **Clinical Pearl:** Pleomorphic adenoma (50–60% of parotid masses) is the most common benign lesion. It is slow-growing, painless, and mobile—exactly matching this patient's presentation. FNAC can reliably diagnose it, allowing safe observation if the patient prefers to avoid surgery. ## Decision Tree: Benign Parotid Mass Management ```mermaid flowchart TD A[Parotid mass:<br/>slow growth, intact CN VII,<br/>well-defined on US]:::outcome --> B[Ultrasound-guided FNAC]:::action B --> C{FNAC Result?}:::decision C -->|Benign<br/>pleomorphic adenoma| D[Offer conservative<br/>observation with<br/>serial US every 6 months]:::action C -->|Benign<br/>Warthin's tumor| D C -->|Malignant| E[Proceed to<br/>superficial parotidectomy<br/>± neck dissection]:::action C -->|Atypia/<br/>Inconclusive| F[Repeat FNAC or<br/>core needle biopsy]:::action D --> G{Patient<br/>preference?}:::decision G -->|Observation| H[Serial US, clinical exam<br/>q 6 months]:::action G -->|Surgery| I[Elective parotidectomy]:::action F --> J{Repeat shows<br/>malignancy?}:::decision J -->|Yes| E J -->|No| D ``` **Mnemonic — FNAC Before Parotid Surgery:** **F**irm diagnosis, **N**o surprises intraoperatively, **A**void unnecessary surgery, **C**onfirm benign (allows observation).